Search

  • Search

    Development services for minimally invasive glaucoma surgery (MIGS) device

    Inven2 AS

    Development services for minimally invasive glaucoma surgery (MIGS) device

    1. Questions deadline

      Jan 20, 11:00 AMJanuary 20, 2026 11:00 AM

    2. Tender submission deadline

      Feb 3, 11:00 AMFebruary 3, 2026 11:00 AM

    3. Competition notice published

      Feb 11, 10:44 AMFebruary 11, 2026 10:44 AM

    4. Change in competition

      Feb 12, 6:39 AMFebruary 12, 2026 6:39 AM

    5. Contract start date

      Apr 30, 10:00 PMApril 30, 2026 10:00 PM

    6. Tender validity period

      May 3, 10:00 AMMay 3, 2026 10:00 AM

    7. Result notice published

      May 19, 12:10 PMMay 19, 2026 12:10 PM

    Brief

    Norway: Tenders/Inven2 AS/Development services for minimally invasive glaucoma surgery (MIGS) device

    Cancelled

    The competition has been cancelled.

    Brief

    Medisinsk og laboratorieutstyr

    Inven2 AS has cancelled a competition for development services for a minimally invasive glaucoma surgery (MIGS) device, intended to lower intraocular pressure. The services, to be delivered in Oslo, involved optimizing stent design, prototyping, and in vitro testing, with an estimated development period of two years and a total contract value of up to 3 million NOK over 60 months. The cancellation was due to invalid offers, as the received bids either deviated from the tender documents or were submitted after the deadline.

    Result

    Reason for cancellation
    Annet
    Number of bids
    2
    Contract value
    Not stated

    About the bid

      We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.Main features of the procedureKonkurransen avlyses da det ikke forelå gyldige tilbud. De mottatte tilbudene var enten avvikende fra konkurransegrunnlaget eller levert etter fristen, og kunne derfor ikke vurderes.

      Contact name
      Eirik Torheim
      Contact phone
      +47 90588644
      Contact email
      e.a.torheim@inven2.com
      Address
      Gaustadalléen 21, 0349 OSLO

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    • Description

      Quality of Technical Solution

    • Description

      Project Management and Delivery Capability

    • Description

      Price

    Qualification requirements

    • Description

      Documented experience from similar projects in scope and complexity within the last 3 years.

      Documentation Requirement

      Documented references of past projects. Minimum requirement: 1 comparable project.

    • Description

      Qualifications and expertise of key personnel proposed for the assignment.

      Documentation Requirement

      CVs and documented competence in relevant fields (e.g., biomedical engineering, regulatory compliance).

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    Inven2 AS
    Title
    Development services for minimally invasive glaucoma surgery (MIGS) device
    Type
    ResultPrequalification
    Main code
    73000000Research and development services and related consultancy services
    Supplemental codes
    33100000Medical equipments33122000Ophthalmology equipment
    Location
    Oslo
    Estimated value
    NOK 3,000,000.00
    Duration
    60 months

    Active similar competitions

    • Oslo Universitetssykehus Hf

      Medisinsk og laboratorieutstyr

      Dokumenter på høring - Anskaffelse av operasjonsmikroskop til øyeavdelingen, Oslo universitetssykehus HF

      Oslo Universitetssykehus HF planlegger anskaffelsen av operasjonsmikroskop til øyeavdelingen. Leverandører inviteres til markedsdialog ved utlysning av dokumenter på høring for å gi tilbakemeldinger. Carl Zeiss AS har sannsynligvis kontrakten i dag.

      PlanningSep 13, 2026
      Oct 30, 2026(6 days)

    • Oslo Universitetssykehus Hf

      Engroshandel med medisinske og husholdningsvarer

      78129 RH KLM IMM Produksjonsinstrument for celleterapi

      Oslo Universitetssykehus HF trenger et produksjonsinstrument for celleterapi, med opsjon på ytterligere ett instrument, programvare og forbruksmateriell, samt serviceavtaler, for en periode på 10 år. Instrumentet skal brukes til GMP-kompatibel sluttprosessering av celleterapiprodukter (ATMP), inkludert CAR-T-celler, ved Rikshospitalet i Oslo. Løsningen skal støtte en standardisert, automatisert og funksjonelt lukket arbeidsflyt for sluttprosessering, og bidra til redusert operatøravhengighet og kontaminasjonsrisiko. Miltenyi Biotech Norden AB har en lignende kontrakt i dag.

      CompetitionSep 21, 2026
      Oct 26, 2026(2 days)